Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
(–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
2006824 citationsCarl L. Keen, Harold H. Schmitz et al.profile →
Copper, oxidative stress, and human health
2005742 citationsJanet Y. Uriu‐Adams, Carl L. Keenprofile →
Influence of ashing techniques on the analysis of trace elements in animal tissue
1981428 citationsCarl L. Keen, Bo Lönnerdal et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Carl L. Keen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl L. Keen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl L. Keen more than expected).
This network shows the impact of papers produced by Carl L. Keen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl L. Keen. The network helps show where Carl L. Keen may publish in the future.
Co-authorship network of co-authors of Carl L. Keen
This figure shows the co-authorship network connecting the top 25 collaborators of Carl L. Keen.
A scholar is included among the top collaborators of Carl L. Keen based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Carl L. Keen. Carl L. Keen is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ilomäki, Jenni, et al.. (2019). Medication Regimen Complexity In 8 Australian Residential Aged Care Facilities: Impact Of Age, Length Of Stay, Comorbidity, Frailty, And Dependence In Activities Of Daily Living. SHILAP Revista de lepidopterología.1 indexed citations
Chang, Christopher, et al.. (1993). The influence of chronic yogurt consumption on populations of young and elderly adults. 9(1). 53–64.51 indexed citations
Halpern, G. M., et al.. (1991). Influence of long-term yoghurt consumption in young adults. 7(4). 205–210.74 indexed citations
12.
Walter, R.M., Toshikazu Aoki, & Carl L. Keen. (1991). Acute oral manganese administration does not consistently affect glucose tolerance in non-diabetic and type II diabetic humans. The Journal of Trace Elements in Experimental Medicine. 4(2). 73–79.6 indexed citations
Halsted, C H & Carl L. Keen. (1990). Alcoholism and micronutrient metabolism and deficiencies.. European Journal of Gastroenterology & Hepatology. 2(6). 399–405.24 indexed citations
Keen, Carl L., et al.. (1985). Vanadium toxicity in adult and developing rats: Role of peroxidative damage. Federation Proceedings. 44(3).1 indexed citations
17.
Keen, Carl L., et al.. (1984). Copper bioavailability from human milk, infant formulas and cow's milk using the suckling rat. Federation Proceedings. 43(3).2 indexed citations
18.
Hurley, L. S., Carl L. Keen, & Bo Lönnerdal. (1983). Aspects of trace element interactions during development.. PubMed. 42(6). 1735–9.32 indexed citations
19.
Keen, Carl L., et al.. (1982). Iron supplementation of milk through iron-lactoferrin: Effect on tissue iron and manganese. Federation Proceedings. 41(3).2 indexed citations
20.
Keen, Carl L., et al.. (1979). Transfer of zinc, copper, and iron as nitrilotriacetic acid (NTA) chelates into rat milk and tissues. Federation Proceedings. 38.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.